<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-131634</identifier>
<setSpec>1575-0922</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Prognostic factors of follicular thyroid carcinoma</dc:title>
<dc:description xml:lang="en">Introduction Most prognostic studies in differentiated carcinoma have included a high number of papillary carcinomas and few follicular carcinomas, and not all of their conclusions therefore apply to the latter. Objective To analyze the prognostic factors of follicular thyroid carcinoma. Patients and methods Selection criteria: Patients with histological diagnosis of follicular carcinoma who had undergone potentially curative surgery, had no disseminated disease at diagnosis, and had been followed up for at least 5 years. Study Variables: Tumor recurrence was defined as: 1) tumor lesions with cytological analysis suggesting malignancy and/or 2) patients with total thyroidectomy with thyroglobulin levels &gt;2 ng/mL. Clinical, therapeutic, and histological parameters were analyzed to assess prognostic factors. Results Recurrence was found in 25 (38%) of the 66 study patients during a follow-up period of 99 ± 38 months. Most patients with recurrence (n = 20) had increased Tg levels without anatomical location, and were initially treated with radioactive I131. In the remaining 5 cases, surgical (..) (AU)</dc:description>
<dc:creator>Parrilla, Pascual</dc:creator>
<dc:creator>Ferri, Belén</dc:creator>
<dc:creator>Ríos, Antonio</dc:creator>
<dc:creator>Rodríguez, José M</dc:creator>
<dc:creator>Martínez-Barba, Enrique</dc:creator>
<dc:creator>Torregrosa, Núria M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción La mayoría de los estudios pronósticos en el carcinoma diferenciado incluyen un alto número de carcinomas papilares y pocos foliculares, por lo que no todas sus conclusiones son aplicables a este último Objetivo Analizar los factores pronósticos, tanto clínicos, histológicos como terapéuticos, del carcinoma folicular de tiroides. Pacientes y métodos Criterios de selección: pacientes con el diagnóstico histológico de carcinoma folicular, sin enfermedad diseminada al diagnóstico, con cirugía potencialmente curativa, y con un seguimiento mínimo de 5 años. Variables de estudio: se consideró recidiva del tumor: a) lesiones tumorales con citología sospechosa de malignidad; y/o b) el aumento de los niveles de tiroglobulina mayor de 2 ng/ml en pacientes con tiroidectomía total. Para valorar los factores pronósticos se analizan variables clínicas, terapéuticas e histológicas. Estadística: curvas de supervivencia aplicando el test de Breslow. Modelo de regresión de Cox. Resultados Se han presentado 25 recidivas (38%) en los 66 pacientes estudiados. La mayoría eran recidivas analíticas (n = 20) que fueron tratadas con I-131. En los casos restantes(..) (AU)</dc:description>
<dc:source>Endocrinol Nutr;62(1): 11-18, ene. 2015. tab</dc:source>
<dc:identifier>ibc-131634</dc:identifier>
<dc:title xml:lang="es">Factores pronósticos del carcinoma folicular de tiroides</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d9554^s22053</dc:subject>
<dc:subject>^d11812</dc:subject>
<dc:subject>^d22696^s22053</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d14353^s22074</dc:subject>
<dc:subject>^d974^s22073</dc:subject>
<dc:subject>^d31586^s22053</dc:subject>
<dc:type>article</dc:type>
<dc:date>201501</dc:date>
</metadata>
</record>
</ibecs-document>
